Lately in the Boston life sciences industry, a Newton biotech cut 20% of its workforce, Novartis signed a deal with a Waltham ...

A well-placed biotech investor says U.S. policies are straining life sciences startups — and more disruption is coming.

Australian biotech giant CSL Ltd said on Tuesday it plans to trim its research and development division across six global locations and would rely more on external partnerships, a move that will cut ...

One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.

Wacker Chemie AG (Munich, Germany) has opened the Wacker Biotechnology Center in Munich. Eminent politicians and guests from ...

It’s called the Amgen Biotech Experience and for a number of teachers across the Piedmont, it could be the key to helping their students learn all about biotechnology. They have come to North Carolina ...